This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nelson, H. H. Articles by Kelsey, K. T. Search for Related Content PubMed PubMed Citation Articles by Nelson, H. H. Articles by Kelsey, K. T.

k-ras Mutation and Occupational Asbestos Exposure in Lung Adenocarcinoma

Asbestos-related Cancer without Asbestosis¹

Department of Cancer Cell Biology [H. H. N., K. T. K.] and Occupational Health Program [D. C. C.], Harvard School of Public Health, Boston, Massachusetts 02115; Pulmonary and Critical Care Unit, Department of Medicine [D. C. C.], Department of Pathology [E. J. M.], and Thoracic Surgery Unit, Department of Surgery [J. C. W.], Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114; and Laboratory for Molecular Epidemiology, Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California 94143 [J. K. W.]

Environmental carcinogen exposure is requisite for the development of nearly all lung cancer, and it is well known that asbestos exposure interacts synergistically with tobacco smoke to induce lung cancer. However, the precise molecular lesions induced by asbestos are unknown. Furthermore, it is also unknown whether asbestos carcinogenesis proceeds in a fashion independent of or dependent upon the induction of fibrosis in workers with high asbestos exposures. Previous studies have suggested that asbestos is associated with the presence of a k-ras mutation in adenocarcinoma of the lung. We aimed to test whether occupational asbestos exposure was associated with k-ras codon 12 mutations in lung adenocarcinoma tumors and to determine whether this was conditional on the presence of asbestosis. All newly diagnosed, resectable lung cancer patients receiving treatment at the Massachusetts General Hospital between November 1992 and December 1996 were eligible to participate. Because k-ras mutation is very strongly associated with adenocarcinoma, and men were more likely to be occupationally exposed to asbestos, the study was restricted to males with this histological diagnosis. There were 84 male patients with available questionnaire-derived work history data and paraffin-embedded tumor tissue for determination of k-ras mutation status. Chest radiographic evaluation was done for all of the patients who reported occupational exposure to asbestos. The prevalence of k-ras mutation was higher among those with a history of occupational asbestos exposure (crude odds ratio, 4.8; 95% confidence interval, 1.5–15.4) compared to those without asbestos exposure, and this association remained after adjustment for age and pack-years smoked (adjusted odds ratio, 6.9; 95% confidence interval, 1.7–28.6). An index score that weights both the dates of exposure and the estimated intensity of exposure indicated that those with k-ras mutations had significantly greater asbestos exposures than those without mutations (P < 0.01). Analysis of the descriptive components of exposure indicated that the duration of exposure was not associated with k-ras mutation, but that the time since initial exposure was significantly associated with mutation status. The association of k-ras mutation and reported asbestos exposure was not dependent on the presence of radiographic evidence of asbestos-related disease. These data suggest that asbestos exposure increases the likelihood of mutation at k-ras codon 12 and that this process occurs independently of the induction of interstitial fibrosis.

This article has been cited by other articles:

				M. A. Jackson, I. Lea, A. Rashid, S. D. Peddada, and J. K. Dunnick Genetic Alterations in Cancer Knowledge System: Analysis of Gene Mutations in Mouse and Human Liver and Lung Tumors Toxicol. Sci., April 1, 2006; 90(2): 400 - 418. [Abstract] [Full Text] [PDF]

				D. Bouros, K. Hatzakis, H. Labrakis, and K. Zeibecoglou Association of Malignancy With Diseases Causing Interstitial Pulmonary Changes* Chest, April 1, 2002; 121(4): 1278 - 1289. [Abstract] [Full Text] [PDF]

				J. Alguacil, M. Porta, N. Malats, T. Kauppinen, M. Kogevinas, F. G. Benavides, T. Partanen, and A. Carrato Occupational exposure to organic solvents and K-ras mutations in exocrine pancreatic cancer Carcinogenesis, January 1, 2002; 23(1): 101 - 106. [Abstract] [Full Text] [PDF]

				H. H. Nelson, D. C. Christiani, E. J. Mark, J. K. Wiencke, J. C. Wain, and K. T. Kelsey Implications and Prognostic Value of K-ras Mutation for Early-Stage Lung Cancer in Women J Natl Cancer Inst, December 1, 1999; 91(23): 2032 - 2038. [Abstract] [Full Text] [PDF]